Zobrazeno 1 - 10
of 591
pro vyhledávání: '"Xiao X Wei"'
Autor:
Neeraj Agarwal, Sabina Signoretti, David F McDermott, Toni K Choueiri, Wanling Xie, John A Steinharter, Nieves Martinez-Chanza, Bradley A McGregor, Lauren C Harshman, Abhishek Tripathi, Xiao X Wei, Edwin Lin, Abdallah Flaifel, Emily N Stern Gatof, Gabrielle Bouchard, Justin H Fleischer, Connor Gray, Charlene Mantia, Linda Thompson, Marios Giannakis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background CD73–adenosine signaling in the tumor microenvironment is immunosuppressive and may be associated with aggressive renal cell carcinoma (RCC). We investigated the prognostic significance of CD73 protein expression in RCC leveraging nephre
Externí odkaz:
https://doaj.org/article/fdf81e1da90d4c78b0738c85b10bd5c7
Autor:
Guru Sonpavde, Sarah Abou Alaiwi, Amin H Nassar, Pier Vitale Nuzzo, Ronan Flippot, Bradley A McGregor, Lauren C Harshman, Gregory R Pond, Catherine Curran, Kerry L Kilbridge, Xiao X Wei, Toni Choueiri
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs). Although the incidence and prevalence of irAEs have been well characterized in the literature, less is known about the cumulative incidence rate
Externí odkaz:
https://doaj.org/article/f9a53e784a40492e874a776edb028735
Autor:
Shuang G. Zhao, Jamie M. Sperger, Jennifer L. Schehr, Rana R. McKay, Hamid Emamekhoo, Anupama Singh, Zachery D. Schultz, Rory M. Bade, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Camila I. Hernandez, Serena K. Wolfe, Richel D. Mayberry, Hannah M. Krause, Matt Bootsma, Kyle T. Helzer, Nicholas Rydzewski, Hamza Bakhtiar, Yue Shi, Grace Blitzer, Christos E. Kyriakopoulos, David Kosoff, Xiao X. Wei, John Floberg, Nan Sethakorn, Marina Sharifi, Paul M. Harari, Wei Huang, Himisha Beltran, Toni K. Choueiri, Howard I. Scher, Dana E. Rathkopf, Susan Halabi, Andrew J. Armstrong, David J. Beebe, Menggang Yu, Kaitlin E. Sundling, Mary-Ellen Taplin, Joshua M. Lang
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 21 (2022)
Background Neuroendocrine prostate cancer (NEPC) is an aggressive subtype, the presence of which changes the prognosis and management of metastatic prostate cancer.Methods We performed analytical validation of a Circulating Tumor Cell (CTC) multiplex
Externí odkaz:
https://doaj.org/article/ec5e2f5145314e94b0c25808c0d5eee0
Autor:
Andrea K. Miyahira, Jessica E. Hawley, Remi Adelaiye‐Ogala, Jeremie Calais, Lucia Nappi, Ravi Parikh, Tyler M. Seibert, Elizabeth V. Wasmuth, Xiao X. Wei, Kenneth J. Pienta, Howard R. Soule
Publikováno v:
The Prostate. 83:207-226
The 2022 Coffey-Holden Prostate Cancer Academy (CHPCA) Meeting, "Exploring New Frontiers in Prostate Cancer Research," was held from June 23 to 26, 2022, at the University of California, Los Angeles, Luskin Conference Center, in Los Angeles, CA.The C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45435c04a74dd6986f009b343fa8868e
https://doi.org/10.1002/pros.24461
https://doi.org/10.1002/pros.24461
Autor:
Guru P. Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, Xiao X. Wei, Kerry L. Kilbridge, Richard J. Lee, Evan Y. Yu, Michael Thomas Schweizer, Robert B. Montgomery, Heather H. Cheng, Andrew Caleb Hsieh, Rohit Jain, Jaspreet S. Grewal, Cesar Pico-Navarro, Zarina Gafoor, Teresa Perschy, Petros Grivas
Publikováno v:
Cancer Immunology, Immunotherapy. 72:775-782
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b49568408392f4e14fb47518431a023
https://doi.org/10.1007/s00262-022-03274-6
https://doi.org/10.1007/s00262-022-03274-6
Autor:
Lawrence Fong, Eric J. Small, Peter R. Carroll, Jeffry P. Simko, Christopher Kane, Brian Rini, Terence W. Friedlander, Amy M. Lin, Charles J. Ryan, Matthew R. Cooperberg, Li Zhang, Vinh Dao, Jera Lewis, Serena Kwek, Stephen Chan, Xiao X. Wei
Granulocytic–macrophage colony-stimulating factor (GM-CSF) is used as an adjuvant in cancer vaccine trials and has the potential to enhance antitumor efficacy with immunotherapy; however, its immunologic effects are not fully understood. Here, we r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15b2dc3d6971176da657260486f22107
https://doi.org/10.1158/2326-6066.c.6548824.v1
https://doi.org/10.1158/2326-6066.c.6548824.v1
Autor:
Toni K. Choueiri, Darren Feldman, Robert J. Motzer, Sabina Signoretti, Lauren C. Harshman, James J. Hsieh, Jae Lyun Lee, Sumanta K. Pal, JoAnn Hsu, Fabio A. Schutz, Andre P. Fay, Daniel Y. Heng, J. Connor Wells, Guillermo De Velasco, Daniel Castellano, Eliezer Van Allen, David A. Braun, Xiao X. Wei, Dylan J. Martini, Aly-Khan A. Lalani, Raphael Brandao, Abdallah Flaifel, Stephanie A.M. Wankowicz, Wanling Xie, Dominick Bossé, Rana R. McKay
Programmed death 1 (PD-1) and PD ligand 1 (PD-L1) inhibitors have shown activity in metastatic clear cell renal cell carcinoma (ccRCC). Data on the activity of these agents in patients with non–clear cell RCC (nccRCC) or patients with sarcomatoid/r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc7a3b136f17fc5d33e77f0d7330319b
https://doi.org/10.1158/2326-6066.c.6549214.v1
https://doi.org/10.1158/2326-6066.c.6549214.v1
Autor:
Toni K. Choueiri, Darren Feldman, Robert J. Motzer, Sabina Signoretti, Lauren C. Harshman, James J. Hsieh, Jae Lyun Lee, Sumanta K. Pal, JoAnn Hsu, Fabio A. Schutz, Andre P. Fay, Daniel Y. Heng, J. Connor Wells, Guillermo De Velasco, Daniel Castellano, Eliezer Van Allen, David A. Braun, Xiao X. Wei, Dylan J. Martini, Aly-Khan A. Lalani, Raphael Brandao, Abdallah Flaifel, Stephanie A.M. Wankowicz, Wanling Xie, Dominick Bossé, Rana R. McKay
Includes: Table 1S. Baseline patient and disease characteristics. Table 2S. Tumor mutation burden status. Table 3S. PDL1 expression data. Figure 1S. Overall survival for the total cohort.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050a1b150ce3998dd89220d1a3afb6e9
https://doi.org/10.1158/2326-6066.22539886.v1
https://doi.org/10.1158/2326-6066.22539886.v1
Autor:
Mary-Ellen Taplin, R. Bruce Montgomery, Glenn J. Bubley, Peter S. Nelson, Evan Y. Yu, Rupal S. Bhatt, Eliezer M. Van Allen, Joshua M. Lang, Xiao X. Wei, Zhenwei Zhang, Rosina T. Lis, Lillian Werner, Wanling Xie, Shuang G. Zhao, Jamie M. Sperger, Jett P. Crowdis, Lucia Kwak, Rana R. McKay
Purpose:Enzalutamide is a second-generation androgen receptor (AR) inhibitor that has improved overall survival (OS) in metastatic castration-resistant prostate cancer (CRPC). However, nearly all patients develop resistance. We designed a phase II mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e158728fefca8468154b513ee71b29f8
https://doi.org/10.1158/1078-0432.c.6530376.v1
https://doi.org/10.1158/1078-0432.c.6530376.v1
Autor:
Mary-Ellen Taplin, R. Bruce Montgomery, Glenn J. Bubley, Peter S. Nelson, Evan Y. Yu, Rupal S. Bhatt, Eliezer M. Van Allen, Joshua M. Lang, Xiao X. Wei, Zhenwei Zhang, Rosina T. Lis, Lillian Werner, Wanling Xie, Shuang G. Zhao, Jamie M. Sperger, Jett P. Crowdis, Lucia Kwak, Rana R. McKay
1. Supplementary table 1S describing details of biopsies undergoing WES. 2. Table 2S includes the primers used in the CTC gene expression analysis. 3. Table 3S includes summary of PSA response based on prior treatment. 4. Table 4S includes objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f0d04a9f9f77293a92b271c2386c01
https://doi.org/10.1158/1078-0432.22480128
https://doi.org/10.1158/1078-0432.22480128